Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First night positive airway pressure therapy does not impair sleep quality in obstructive sleep apnea.

Sleep medicine·2026
Same author

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea.

PloS one·2026
Same author

The effects of spectrum, irradiance, and duration of exposure on light-induced melatonin suppression in healthy adults.

Photochemistry and photobiology·2026
Same author

Parapharyngeal Fat Pads as an Obesity-Related Parameter for Apnea-Hypopnea Index Severity.

Journal of sleep research·2026
Same author

Daridorexant in severe obstructive sleep apnea: Effects on sleep-disordered breathing and sleep.

Sleep·2026
Same author

A Multimodal Learning Framework for Detecting Systemic Hypertension in Sleep Apnea Patients Using ECG and PPG Signals.

IEEE journal of biomedical and health informatics·2026

Related Experiment Video

Updated: Jun 6, 2026

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
09:56

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice

Published on: February 14, 2021

Daytime baroreflex sensitivity in patients with primary insomnia.

Jan Giso Peter1, Martin Glos, Alexander Blau

  • 1Sleep Medicine Center, CCM-CC13, Charité Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|November 26, 2010
PubMed
Summary

Primary insomnia may not be linked to daytime autonomic imbalance, specifically baroreflex sensitivity (BRS). This study found no significant differences in BRS between insomnia patients and healthy controls, suggesting insomnia may not increase cardiovascular risk through this pathway.

More Related Videos

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Related Experiment Videos

Last Updated: Jun 6, 2026

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
09:56

Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice

Published on: February 14, 2021

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
10:56

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice

Published on: August 2, 2017

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Autonomic Neuroscience

Background:

  • Insomnia is associated with cardiovascular disease, including hypertension and autonomic dysfunction.
  • Baroreflex sensitivity (BRS) is a key indicator of cardiovascular risk.
  • Investigating BRS in primary insomnia may clarify autonomic function and cardiovascular risk in these patients.

Purpose of the Study:

  • To assess daytime baroreflex sensitivity (BRS) in patients with primary insomnia.
  • To determine if primary insomnia is associated with autonomic imbalance, a non-classical cardiovascular risk marker.

Main Methods:

  • Recruited 21 primary insomnia patients (DSM-IV) and 21 age-matched healthy controls.
  • Excluded confounding sleep disorders like sleep-disordered breathing and periodic limb movements.
  • Measured spontaneous BRS using paced breathing, ECG, and continuous blood pressure monitoring (α index and transfer function analysis).

Main Results:

  • No significant differences in daytime BRS (BRS-α or TF-BRS) were observed between insomnia patients and controls.
  • Heart rate and blood pressure variability in absolute, low, and high-frequency bands also showed no group differences.
  • Primary insomnia was not associated with daytime autonomic imbalance markers like BRS.

Conclusions:

  • Primary insomnia may not be linked to daytime autonomic dysfunction, as indicated by normal baroreflex sensitivity.
  • These findings suggest that daytime autonomic parameters, such as BRS, may not mediate the increased cardiovascular risk observed in primary insomnia.
  • Further research is needed to understand the complex relationship between insomnia and cardiovascular health.